Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (394K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Hemmings-Mieszczak, M.
Right arrow Articles by Wishart, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hemmings-Mieszczak, M.
Right arrow Articles by Wishart, W. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2003, Vol. 31, No. 8 2117-2126
© 2003 Oxford University Press

Independent combinatorial effect of antisense oligonucleotides and RNAi-mediated specific inhibition of the recombinant Rat P2X3 receptor

Maja Hemmings-Mieszczak, Gabriele Dorn, François J. Natt, Jonathan Hall and William L. Wishart

Functional Genomics, Novartis Pharma AG, Lichtstrasse 35, 4002 Basel, Switzerland

*To whom correspondence should be addressed at present address: Friedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, 4058 Basel, Switzerland. Tel: +41 61 6976954; Fax: +41 61 6973976; Email: maja.hemmings{at}fmi.ch

Synthetic 21-bp-long short interfering RNAs (siRNA) can stimulate sequence-specific mRNA degradation in mammalian cell cultures, a process referred to as RNA interference (RNAi). In the present study, the potential of RNAi was compared to the traditional antisense approach, acting mainly via RnaseH, for targeting the recombinant rat pain-related cation-channel P2X3 expressed in CHO-K1 and a rat brain tumour-derived cell line, 33B. Downregulation of the P2X3 receptor was evaluated at the mRNA, protein, and functional levels. In this study, four siRNA duplexes induced up to 95% sequence-specific inhibition of the P2X3 mRNA, independent of the type of 2 nt 3'-overhang modification and the location of the targeted sequences. Furthermore, we detected and characterised an independent combinatorial effect of antisense oligonucleotides (ASOs) and RNAi-mediated specific inhibition of the P2X3 receptor. Enhanced downregulation was observed only when siRNA was combined with nonhomologous ASO, targeting distant regions on the common P2X3 mRNA. The two reagents resulted in more efficient downregulation of P2X3 mRNA when administered in combination rather than separately. To our knowledge, this is the first investigation at the molecular level of the potential benefits of mixed antisense and RNAi-mediated treatment for inhibiting expression of a medically relevant pain-related gene.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
G. Burnstock
Physiology and Pathophysiology of Purinergic Neurotransmission
Physiol Rev, April 1, 2007; 87(2): 659 - 797.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
G. Burnstock
Pathophysiology and therapeutic potential of purinergic signaling.
Pharmacol. Rev., March 1, 2006; 58(1): 58 - 86.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
G. Dorn, S. Patel, G. Wotherspoon, M. Hemmings-Mieszczak, J. Barclay, F. J. C. Natt, P. Martin, S. Bevan, A. Fox, P. Ganju, et al.
siRNA relieves chronic neuropathic pain
Nucleic Acids Res., March 16, 2004; 32(5): e49 - e49.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. J.A. Wood, B. Trulzsch, A. Abdelgany, and D. Beeson
Therapeutic gene silencing in the nervous system
Hum. Mol. Genet., October 15, 2003; 12(90002): R279 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
R. Kretschmer-Kazemi Far and G. Sczakiel
The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides
Nucleic Acids Res., August 1, 2003; 31(15): 4417 - 4424.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.